Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12)

NCT01220752 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT01220752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01220752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Malignant Sinonasal Tumours With Intensity-modulated Radiotherapy (IMRT) and Carbon Ion Boost (C12)
Lead sponsor
Heidelberg University
Phase
Phase 2
Overall status
Completed
Start date
June 17, 2011
Completion date
December 19, 2021
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma and squamous cell carcinoma of the paranasal sinuses, sinonasal malignancies